Literature DB >> 15702921

Isolation of non-toxigenic strains of Clostridium difficile from cases of diarrhea among patients hospitalized in hematology/oncology ward.

Gayane Martirosian1, Adam Szczesny, Stuart H Cohen, Joseph Silva.   

Abstract

Clostridium difficile has become the most common cause of hospital acquired diarrhea after antibiotic treatment. The aim of this study was to determine the frequency of C. difficile associated diarrhea among hematology/oncology ward patients and to characterize isolated strains. Twenty three toxigenic and thirteen non-toxigenic strains were detected among fecal isolates. Antibiotic susceptibility testing to erythromycin and clindamycin demonstrated a high degree of resistance (MIC > 256 ug/ml) to both antibiotics in 9 out of 13 nontoxigenic C. difficle strains. Out of 7 patients with maximal frequency of diarrhea (10 empties/day) in 4 cases non-toxigenic strains of C. difficile were isolated. In these cases duration of diarrhea was longer in time than in cases of diarrhea caused by toxigenic strains. Further investigation with a larger patient population is necessary to better understand the role that non-toxigenic C. difficile strains play in disease development.

Entities:  

Mesh:

Year:  2004        PMID: 15702921

Source DB:  PubMed          Journal:  Pol J Microbiol        ISSN: 1733-1331


  6 in total

1.  Epidemiology of Klebsiella oxytoca-associated diarrhea detected by Simmons citrate agar supplemented with inositol, tryptophan, and bile salts.

Authors:  Vincent C C Cheng; Wing-Cheong Yam; Lee-Lee Tsang; Miranda C Y Yau; Gilman K H Siu; Sally C Y Wong; Jasper F W Chan; Kelvin K W To; Herman Tse; Ivan F N Hung; Josepha W M Tai; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2012-02-22       Impact factor: 5.948

Review 2.  A clinical and epidemiological review of non-toxigenic Clostridium difficile.

Authors:  Mukil Natarajan; Seth T Walk; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2013-05-29       Impact factor: 3.331

3.  The genome of Clostridium difficile 5.3.

Authors:  Aaron E Darling; Paul Worden; Toni A Chapman; Piklu Roy Chowdhury; Ian G Charles; Steven P Djordjevic
Journal:  Gut Pathog       Date:  2014-02-24       Impact factor: 4.181

4.  Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.

Authors:  Susan Secore; Su Wang; Julie Doughtry; Jinfu Xie; Matt Miezeiewski; Richard R Rustandi; Melanie Horton; Rachel Xoconostle; Bei Wang; Catherine Lancaster; Adam Kristopeit; Sheng-Ching Wang; Sianny Christanti; Salvatore Vitelli; Marie-Pierre Gentile; Aaron Goerke; Julie Skinner; Erica Strable; David S Thiriot; Jean-Luc Bodmer; Jon H Heinrichs
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

5.  Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure.

Authors:  Yuan-Pin Hung; Hsiao-Ju Lin; Tai-Chieh Wu; Hsiu-Chuan Liu; Jen-Chieh Lee; Chih-I Lee; Yi-Hui Wu; Lei Wan; Pei-Jane Tsai; Wen-Chien Ko
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

6.  Frequency of antibiotic associated diarrhea caused by Clostridium difficile among hospitalized patients in intensive care unit, Kerman, Iran.

Authors:  Ebrahim Rezazadeh Zarandi; Shahla Mansouri; Nouzar Nakhaee; Farhad Sarafzadeh; Zahra Iranmanesh; Mohammad Moradi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.